ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $828,690 | -8.8% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $908,960 | -1.6% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $924,000 | -4.4% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $967,000 | +7.9% | 23,000 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $896,000 | -2.3% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $917,000 | +10.3% | 23,000 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $831,000 | -52.9% | 23,000 | -46.5% | 0.00% | -66.7% |
| Q2 2021 | $1,763,000 | -58.1% | 43,000 | -55.4% | 0.00% | -62.5% |
| Q1 2021 | $4,209,000 | -12.9% | 96,500 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $4,830,000 | +27.6% | 96,500 | +7.2% | 0.01% | +25.0% |
| Q3 2020 | $3,786,000 | +11.4% | 90,000 | +28.6% | 0.01% | 0.0% |
| Q2 2020 | $3,398,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |